Related Experiment Video

Updated: Aug 7, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Is liver analysis still required for the diagnosis of primary hyperoxaluria type 2?

Gill Rumsby

    Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
    |July 6, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
    07:12

    Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

    Published on: June 2, 2023

    Biochemical Measurement of Neonatal Hypoxia
    13:13

    Biochemical Measurement of Neonatal Hypoxia

    Published on: August 24, 2011

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
    06:26

    Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

    Published on: July 18, 2025

    Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
    07:12

    Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

    Published on: June 2, 2023

    Biochemical Measurement of Neonatal Hypoxia
    13:13

    Biochemical Measurement of Neonatal Hypoxia

    Published on: August 24, 2011

    Related Concept Videos

    Urine Studies I: Urinalysis01:29

    Urine Studies I: Urinalysis

    Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

    Articles linked to this work by shared authors, journal, and citation graph.

    Global genetic prevalence estimates of primary hyperoxaluria are greater than previously reported.

    Clinical kidney journal·2025

    Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.

    The Journal of biological chemistry·2025

    A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT.

    Journal of inherited metabolic disease·2025

    SMART Stone Multidisciplinary Team (MDT) and patient care: recommendations for the adult high-risk kidney stone patient pathway.

    World journal of urology·2025

    Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.

    Nature reviews. Nephrology·2023

    Genetic assessment in primary hyperoxaluria: why it matters.

    Pediatric nephrology (Berlin, Germany)·2022

    Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    Protocol kidney biopsy in the management of proliferative (class III/IV) lupus nephritis: barking up the wrong tree!

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    CKD risk with tegoprazan versus proton pump inhibitors.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    Specific aspects of kidney care for Africans living in Europe.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    Cullin 3 ubiquitin ligase regulates redox defense and metabolic programs in proximal tubule cells.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    Sex in CKD trials: representation and treatment effects of cardiorenoprotective therapies.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

    Rapid identification of blood using RT-RPA: A pilot study.

    Journal of forensic sciences·2026

    A signal-locked clamped hybridization chain reaction nanoamplifier for rapid and highly sensitive analysis of Aβ42.

    Talanta·2026

    Electrochemical sensing of cell viability: A scalable platform from 2D monolayers to 3D tissue models.

    iScience·2026

    GenoTox Cell Counter: A mobile App to standardize cell counting in genotoxicity testing.

    Genetics and molecular biology·2026

    Amplification of RNA for identification of Zika and HCV in whole blood.

    Science advances·2026

    Ultrasensitive, Amplification-Free RNA Detection Using Nanodiamond Quantum Sensors.

    Nano letters·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us